Serial #79446283
LIVE

Serial Number

79446283

Owner

MEDIOLANUM FARMACEUTICI S.p.A.

Attorney

John Zaccaria

Filing Date

Jan 7, 2026

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79446283 Trademark

Serial Number: 79446283

Serial #79446283 is a trademark filed by MEDIOLANUM FARMACEUTICI S.p.A. on January 7, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

MEDIOLANUM FARMACEUTICI S.p.A. (19 trademarks)

VIA S.G. Cottolengo 15/31
20143 Milano , IT

Entity Type: 99

Trademark Details

Filing Date

January 7, 2026

Registration Date

Not Registered

Published for Opposition

July 21, 2026

Goods & Services

Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing services; advertising services

Arranging and conducting of in-person educational forums in the field of pharmaceuticals; Educational services in the nature of pharmaceuticals schools; providing information in the field of education; providing online electronic publications, not downloadable, namely, brochures in the field of pharmaceuticals; arranging and conducting of conferences in the field of pharmaceuticals; arranging and conducting of congresses in the field of pharmaceuticals; arranging and conducting of colloquiums in the field of pharmaceuticals; arranging and conducting of seminars in the field of pharmaceuticals; arranging and conducting of symposiums in the field of pharmaceuticals

Dietetic foods adapted for medical purposes; teeth filling material; herbicides; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; pharmaceutical preparations for the treatment of neuroendocrine disorders; fungicides; food for babies; dietetic substances in the nature of dietetic foods adapted for medical use; disinfectants; nutritional supplements for medical purposes; homogenized food adapted for medical purposes; analgesics; anaesthetics; antibiotics; anti-inflammatories; Food supplements, namely, anti-oxidants; dietetic beverages adapted for medical purposes; vitamin supplement patches; dietary fibre supplements; glycerine for medical purposes; immunostimulants; protein dietary supplements; mineral dietary supplements; dietary supplements for human beings; medicated lotions for pharmaceutical purposes; narcotics being pharmaceuticals for the treatment of pain; opiates being pharmaceuticals for the treatment of pain; Pharmaceutical preparations in the form of pastilles for the treatment of cancer; Pharmaceutical preparations in the form of pastilles for the treatment of pain; Pharmaceutical preparations in the form of pastilles for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; Pharmaceutical preparations in the form of pastilles for the treatment of neuroendocrine disorders; chemical preparations for pharmaceutical purposes for the treatment of cancer; chemical preparations for pharmaceutical purposes for the treatment of pain; chemical preparations for pharmaceutical purposes for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemical preparations for pharmaceutical purposes for the treatment of neuroendocrine disorders; chemical preparations for medical purposes for the treatment of cancer; chemical preparations for medical purposes for the treatment of pain; chemical preparations for medical purposes for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemical preparations for medical purposes for the treatment of pain; chemical preparations for medical purposes for the treatment of neuroendocrine disorders; Aloe vera preparations for pharmaceutical purposes; phytotherapy preparations for medical purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer-related conditions; vitamin preparations; chemico-pharmaceutical preparations for the treatment of cancer; chemico-pharmaceutical preparations for the treatment of pain; chemico-pharmaceutical preparations for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemico-pharmaceutical preparations for the treatment of neuroendocrine disorders

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 15, 2026 NONP
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 22, 2026 GNEN
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 22, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jun 22, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 22, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 19, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 19, 2026 TROA
REFUSAL PROCESSED BY IB
Jun 4, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 21, 2026 RFCS
REFUSAL PROCESSED BY MPU
May 21, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 2, 2026 RFCR
NON-FINAL ACTION WRITTEN
Apr 1, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 20, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 19, 2026 REPR